Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

New compounds with carborane showed anti-androgen effects similar to flutamide.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

TNF family proteins are crucial for the development of skin features like hair, teeth, and mammary glands.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Innovative cosmetics could safely change hair color by targeting biological hair pigmentation processes.

Hormones and genes affect hair growth and male baldness.

Activin A and follistatin control when hair cells develop in mouse ears.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Sebum is essential for skin health but can cause acne if unbalanced.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Mice with human gene experienced hair loss when treated with DHT.